mCRC

Castres, France, May 22, 2026 Pierre Fabre Laboratories has announced that the Committee for Medicinal Products for Human Use...

SAN DIEGO, May 04, 2026 Oncolytics Biotech® Inc. has reported compelling durability data from its REO 022 study, highlighting...

SAN DIEGO, Calif., April 21, 2026 Cardiff Oncology, Inc. announced it will present updated Phase 2 data for its...

Princeton, New Jersey, U.S. | April 15, 2026 PDS Biotechnology has announced the publication of positive interim Phase 2...